Tag: naion
-
FDA Requires New Label Warnings on GLP-1 Drugs Over Rare Eye Condition Risk
The FDA is requiring makers of GLP-1 receptor agonist medications to add warnings about a potential increased risk of NAION, a rare eye condition that can cause permanent vision loss.
HealthPolitics and GovernmentFederal GovernmentMedical ScienceLaw Enforcement US Food and Drug AdministrationGLP-1 receptor agonistsNAIONDrug safety labelingVision lossMedWatchType 2 diabetesFood RecallsFDADrugs